Publications by authors named "M Irem Baharoglu"

Article Synopsis
  • Research investigates sex disparities in stroke treatment, highlighting that women experience worse functional outcomes than men after acute ischemic stroke (AIS).
  • The study analyzed data from 58,632 AIS patients in the Netherlands, focusing on treatments used, time metrics, and functional outcomes at three months post-treatment.
  • Results showed women were older, had longer onset-to-door times, and faced higher odds of poor outcomes compared to men, even when adjusting for age and initial stroke severity.
View Article and Find Full Text PDF

Background: Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably related to the dissolution of the blood clot at the site of the aneurysm rupture by natural fibrinolytic activity. This review is an update of previously published Cochrane Reviews.

View Article and Find Full Text PDF
Article Synopsis
  • The Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration was established in 2010 to study the effectiveness and safety of intravenous thrombolysis (IVT) and has now evolved to include endovascular treatment (EVT) in a new registry called EVA-TRISP.
  • The collaboration involves 20 stroke centers committed to collecting detailed data on patients for better accuracy and investigating specific research questions regarding EVT and its outcomes.
  • The initiative aims to fill crucial gaps in knowledge about EVT's safety and effectiveness in various patient groups that may not be addressed by randomized controlled trials (RCTs), thus supporting clinical decision-making for stroke physicians.
View Article and Find Full Text PDF

Antithrombotic therapy influences clinical outcome after spontaneous intracerebral hemorrhage (ICH). However, evidence on the effect of different antithrombotic therapies on outcome and a comparison between different therapies is scarce, while this is important for medical decision making. Therefore, we investigated clinical outcome after ICH stratified by type of antithrombotic therapy.

View Article and Find Full Text PDF